Transcription factor-induced enhancer modulations during cell fate conversions

Current Opinion in Genetics and Development

Volumn 23, Issue 5, 2013, Pages 562-567

  Van Oevelen, C ^a   Kallin, E M ^a   Graf, T ^a  

^a CENTRE FOR GENOMIC REGULATION CRG   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; HISTONE DEACETYLASE 7; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX5;

CELL FATE; CELL LINEAGE; CELL TRANSDIFFERENTIATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA MODIFICATION; EMBRYONIC STEM CELL; ENHANCER REGION; GENE EXPRESSION; GENE SILENCING; HETEROCHROMATIN; HISTONE METHYLATION; HUMAN; MACROPHAGE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROCESSING; REVIEW;

CELL DIFFERENTIATION; CELL LINEAGE; CHROMATIN; EMBRYONIC STEM CELLS; ENHANCER ELEMENTS, GENETIC; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NUCLEAR REPROGRAMMING; TRANSCRIPTION FACTORS; TRANSCRIPTOME;

EID: 84883775457     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2013.07.003     Document Type: Review

References (50)

1. Graf T., Enver T. Forcing cells to change lineages. Nature 2009, 462:587-594.
2. Ladewig J., Koch P., Brustle O. Leveling Waddington: the emergence of direct programming and the loss of cell fate hierarchies. Nat Rev Mol Cell Biol 2013, 14:225-236.
3. Morris S.A., Daley G.Q. A blueprint for engineering cell fate: current technologies to reprogram cell identity. Cell Res 2013, 23:33-48.
4. Biran A., Meshorer E. Concise review: chromatin and genome organization in reprogramming. Stem Cells 2012, 30:1793-1799.
5. Cantone I., Fisher A.G. Epigenetic programming and reprogramming during development. Nat Struct Mol Biol 2013, 20:282-289.
6. Papp B., Plath K. Epigenetics of reprogramming to induced pluripotency. Cell 2013, 152:1324-1343.
7. Heintzman N.D., et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 2007, 39:311-318.
8. Heinz S., et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 2010, 38:576-589.
9. Heintzman N.D., et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 2009, 459:108-112.
10. Tolhuis B., Palstra R.J., Splinter E., Grosveld F., de Laat W. Looping and interaction between hypersensitive sites in the active beta-globin locus. Mol Cell 2002, 10:1453-1465.
11. Natoli G. Maintaining cell identity through global control of genomic organization. Immunity 2010, 33:12-24.
12. Hu M., et al. Multilineage gene expression precedes commitment in the hemopoietic system. Genes Dev 1997, 11:774-785.
13. Hoogenkamp M., et al. Early chromatin unfolding by RUNX1: a molecular explanation for differential requirements during specification versus maintenance of the hematopoietic gene expression program. Blood 2009, 114:299-309.
14. Creyghton M.P., et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A 2010, 107:21931-21936.
15. Rada-Iglesias A., et al. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 2011, 470:279-283.
16. Whyte W.A., et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 2013, 153:307-319.
17. Beisel C., Paro R. Silencing chromatin: comparing modes and mechanisms. Nat Rev Genet 2011, 12:123-135.
18. Trojer P., Reinberg D. Facultative heterochromatin: is there a distinctive molecular signature?. Mol Cell 2007, 28:1-13.
19. Zaret K.S., Carroll J.S. Pioneer transcription factors: establishing competence for gene expression. Genes Dev 2011, 25:2227-2241.
20. Sekiya S., Suzuki A. Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature 2011, 475:390-393.
21. Maison C., Almouzni G. HP1 and the dynamics of heterochromatin maintenance. Nat Rev Mol Cell Biol 2004, 5:296-304.
22. Wang X., Bai L., Bryant G.O., Ptashne M. Nucleosomes and the accessibility problem. Trends Genet 2011, 27:487-492.
23. Siersbaek R., et al. Extensive chromatin remodelling and establishment of transcription factor 'hotspots' during early adipogenesis. EMBO J 2009, 30:1459-1472.
24. Kajimura S., et al. Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex. Nature 2009, 460:1154-1158.
25. Bussmann L.H., et al. A robust and highly efficient immune cell reprogramming system. Cell Stem Cell 2009, 5:554-566.
26. Rapino F., et al. C/EBPalpha induces highly efficient macrophage transdifferentiation of B lymphoma and leukemia cell lines and impairs their tumorigenicity. Cell Rep 2013, 3:1153-1163.
27. Xie H., Ye M., Feng R., Graf T. Stepwise reprogramming of B cells into macrophages. Cell 2004, 117:663-676.
28. Feng R., et al. PU.1 and C/EBPalpha/beta convert fibroblasts into macrophage-like cells. Proc Natl Acad Sci U S A 2008, 105:6057-6062.
29. Davis R.L., Weintraub H., Lassar A.B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987, 51:987-1000.
30. Taberlay P.C., et al. Polycomb-repressed genes have permissive enhancers that initiate reprogramming. Cell 2011, 147:1283-1294.
31. Junion G., et al. A transcription factor collective defines cardiac cell fate and reflects lineage history. Cell 2012, 148:473-486.
32. Takeuchi J.K., Bruneau B.G. Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors. Nature 2009, 459:708-711.
33. Tursun B., Patel T., Kratsios P., Hobert O. Direct conversion of C. elegans germ cells into specific neuron types. Science 2011, 331:304-308.
34. Patel T., Tursun B., Rahe D.P., Hobert O. Removal of Polycomb repressive complex 2 makes C. elegans germ cells susceptible to direct conversion into specific somatic cell types. Cell Rep 2012, 2:1178-1186.
35. Spitz F., Furlong E.E. Transcription factors: from enhancer binding to developmental control. Nat Rev Genet 2012, 13:613-626.
36. Stoilova B., Kowenz-Leutz E., Scheller M., Leutz A. Lymphoid to myeloid cell trans-differentiation is determined by C/EBPbeta structure and post-translational modifications. PLoS ONE 2013, 8:e65169.
37. Kallin E.M., et al. Tet2 facilitates the derepression of myeloid target genes during CEBPalpha-induced transdifferentiation of pre-B cells. Mol Cell 2012, 48:266-276.
38. Li P., et al. Reprogramming of T cells to natural killer-like cells upon Bcl11b deletion. Science 2010, 329:85-89.
39. Talchai C., Xuan S., Lin H.V., Sussel L., Accili D. Pancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure. Cell 2012, 150:1223-1234.
40. Cobaleda C., Busslinger M. Developmental plasticity of lymphocytes. Curr Opin Immunol 2008, 20:139-148.
41. Tagoh H., et al. The mechanism of repression of the myeloid-specific c-fms gene by Pax5 during B lineage restriction. EMBO J 2006, 25:1070-1080.
42. Lluis F., Pedone E., Pepe S., Cosma M.P. Periodic activation of Wnt/beta-catenin signaling enhances somatic cell reprogramming mediated by cell fusion. Cell Stem Cell 2008, 3:493-507.
43. Lluis F., et al. T-cell factor 3 (Tcf3) deletion increases somatic cell reprogramming by inducing epigenome modifications. Proc Natl Acad Sci U S A 2011, 108:11912-11917.
44. Revilla I.D.R., et al. The B-cell identity factor Pax5 regulates distinct transcriptional programmes in early and late B lymphopoiesis. EMBO J 2012, 31:3130-3146.
45. Richard J.P., et al. Direct in vivo cellular reprogramming involves transition through discrete, non-pluripotent steps. Development 2011, 138:1483-1492.
46. Barneda-Zahonero B., et al. HDAC7 is a repressor of myeloid genes whose downregulation is required for transdifferentiation of pre-B cells into macrophages. PLoS Genet 2013, 9:e1003503.
47. Pijnappel W.W., et al. A central role for TFIID in the pluripotent transcription circuitry. Nature 2013, 495:516-519.
48. Hagemeier C., Bannister A.J., Cook A., Kouzarides T. The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc Natl Acad Sci U S A 1993, 90:1580-1584.
49. Nerlov C., Ziff E.B. CCAAT/enhancer binding protein-alpha amino acid motifs with dual TBP and TFIIB binding ability co-operate to activate transcription in both yeast and mammalian cells. EMBO J 1995, 14:4318-4328.
50. Bauknecht T., Shi Y. Overexpression of C/EBPbeta represses human papillomavirus type 18 upstream regulatory region activity in HeLa cells by interfering with the binding of TATA-binding protein. J Virol 1998, 72:2113-2124.